172 related articles for article (PubMed ID: 8123653)
1. Treatment of mild hyperhomocysteinemia in vascular disease patients.
Franken DG; Boers GH; Blom HJ; Trijbels FJ; Kloppenborg PW
Arterioscler Thromb; 1994 Mar; 14(3):465-70. PubMed ID: 8123653
[TBL] [Abstract][Full Text] [Related]
2. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.
van den Berg M; Franken DG; Boers GH; Blom HJ; Jakobs C; Stehouwer CD; Rauwerda JA
J Vasc Surg; 1994 Dec; 20(6):933-40. PubMed ID: 7990188
[TBL] [Abstract][Full Text] [Related]
3. Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study.
de Jong SC; Stehouwer CD; van den Berg M; Geurts TW; Bouter LM; Rauwerda JA
J Intern Med; 1999 Jul; 246(1):87-96. PubMed ID: 10447230
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.
Van den Berg M; Boers GH; Franken DG; Blom HJ; Van Kamp GJ; Jakobs C; Rauwerda JA; Kluft C; Stehouwert CD
Eur J Clin Invest; 1995 Mar; 25(3):176-81. PubMed ID: 7781664
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease.
Fermo I; Vigano' D'Angelo S; Paroni R; Mazzola G; Calori G; D'Angelo A
Ann Intern Med; 1995 Nov; 123(10):747-53. PubMed ID: 7574192
[TBL] [Abstract][Full Text] [Related]
6. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
[TBL] [Abstract][Full Text] [Related]
7. Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular diseases.
Freyburger G; Labrouche S; Sassoust G; Rouanet F; Javorschi S; Parrot F
Thromb Haemost; 1997 Mar; 77(3):466-71. PubMed ID: 9065995
[TBL] [Abstract][Full Text] [Related]
8. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
[TBL] [Abstract][Full Text] [Related]
9. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction.
Leeda M; Riyazi N; de Vries JI; Jakobs C; van Geijn HP; Dekker GA
Am J Obstet Gynecol; 1998 Jul; 179(1):135-9. PubMed ID: 9704778
[TBL] [Abstract][Full Text] [Related]
10. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia.
Ubbink JB; Vermaak WJ; van der Merwe A; Becker PJ
Am J Clin Nutr; 1993 Jan; 57(1):47-53. PubMed ID: 8416664
[TBL] [Abstract][Full Text] [Related]
11. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
Wuillemin WA; Solenthaler M
Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial.
Bostom AG; Gohh RY; Beaulieu AJ; Nadeau MR; Hume AL; Jacques PF; Selhub J; Rosenberg IH
Ann Intern Med; 1997 Dec; 127(12):1089-92. PubMed ID: 9412311
[TBL] [Abstract][Full Text] [Related]
13. Vitamin requirements for the treatment of hyperhomocysteinemia in humans.
Ubbink JB; Vermaak WJ; van der Merwe A; Becker PJ; Delport R; Potgieter HC
J Nutr; 1994 Oct; 124(10):1927-33. PubMed ID: 7931701
[TBL] [Abstract][Full Text] [Related]
14. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.
de Jong SC; Stehouwer CD; van den Berg M; Kostense PJ; Alders D; Jakobs C; Pals G; Rauwerda JA
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1316-24. PubMed ID: 10323785
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
16. Methionine loading test is necessary for detection of hyperhomocysteinemia.
van der Griend R; Haas FJ; Duran M; Biesma DH; Meuwissen OJ; Banga JD
J Lab Clin Med; 1998 Jul; 132(1):67-72. PubMed ID: 9665374
[TBL] [Abstract][Full Text] [Related]
17. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance.
Boers GH
Thromb Haemost; 1997 Jul; 78(1):520-2. PubMed ID: 9198207
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of hyperhomocysteinemia in vascular disease: comparative study of thrombotic venous disease vis-à-vis occlusive arterial disease.
Bhargava S; Parakh R; Manocha A; Ali A; Srivastava LM
Vascular; 2007; 15(3):149-53. PubMed ID: 17573020
[TBL] [Abstract][Full Text] [Related]
20. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
Booth GL; Wang EE
CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
